- 
                        REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
                        30 Oct 2025 11:58 GMT
                         …  therapy for the treatment of Duchenne muscular dystrophy, as well as the successful …  in late-stage development for Duchenne with a differentiated microdystrophin construct … -and-initiates-commercial-production-in-duchenne-gene-therapy-program-302599520.html … 
- 
                        Wearable Robots You Can Wear Like Clothes
                        30 Oct 2025 21:40 GMT
                         …  muscular weakness, including those with Duchenne muscular dystrophy, the wearable shoulder-assist robot … 
- 
                        Making More Supply to Meet the Demands of Muscle Cell Therapy
                        30 Oct 2025 20:04 GMT
                        
                           … Duchenne muscular dystrophy and other degenerative muscle diseases.  
                          “In the case of Duchenne muscular dystrophy … provided by patients with Duchenne muscular dystrophy.
                          “We saw  …  for patients with Duchenne muscular dystrophy or other degenerative diseases …
                         
- 
                        New method yields up to twice as many therapeutic myogenic cells as previous protocols
                        30 Oct 2025 18:16 GMT
                        
                           … 39;s disease or Duchenne muscular dystrophy.
                          Scientists have long  … Duchenne muscular dystrophy and other degenerative muscle diseases.
                          In the case of Duchenne muscular dystrophy …  for patients with Duchenne muscular dystrophy or other degenerative diseases …
                         
- 
                        Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
                        30 Oct 2025 14:29 GMT
                        
                           … : Two mortalities attributed to the Duchenne muscular dystrophy therapy Elevidys and one to …  investigational asset for limb-girdle muscular dystrophy.
                          Deaths have also occurred in …
                         
- 
                        Antisense & RNAi Therapeutics Market to Reach USD 17.74 Billion by 2032, Driven by Gene-Silencing Breakthroughs
                        30 Oct 2025 13:20 GMT
                         …  received FDA priority review for Duchenne muscular dystrophy, highlighting the accelerating RNA drug … 
- 
                        Solid Biosciences to Participate at Upcoming Investor Conferences
                        30 Oct 2025 12:00 GMT
                         …  diseases, including SGT-003 for Duchenne muscular dystrophy (Duchenne), SGT-212 for Friedreich’s …  by those directly impacted by Duchenne, Solid’s mission is to … 
- 
                        Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
                        30 Oct 2025 11:50 GMT
                        
                           …  gene therapy for patients with Duchenne muscular dystrophy (DMD).
                          The Company's …  potential treatment for patients with Duchenne muscular dystrophy (DMD). Administered intrathecally, this approach …
                         
- 
                        Dr. Pannie Trifillis Honored at Cyprus Women of the Year Awards
                        30 Oct 2025 11:52 GMT
                         …  drugs, Translarna and Evrysdi for Duchenne muscular dystrophy and Spinal Muscular Atrophy, respectively … 
- 
                        Fabric muscles thinner than hair could reshape wearable robotics design
                        30 Oct 2025 05:39 GMT
                        
                           …  57 percent among patients with Duchenne muscular dystrophy and other neuromuscular disorders.
                          Beyond …